China · Series B startup

Who invested in Alphamab Oncology

2 rounds we have observed, with the 9 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Funding summaryUpdated 26 Oct 2026

$160Mraised across 2 rounds since 2018, from 2 sources

$100MSeries A$60MSeries B
Latest round
Series B, $60MMay 2019
Led by
Hudson Bay Capital Management LP
Biggest round
$100MSeries A · Nov 2018
Investors
9 (1 led)
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2019
$100MSeries A$60MSeries B
First round
Series A, $100M
Nov 2018
Biggest round
$100M
Series A · Nov 2018
Between rounds
6 months
from the last two

The rounds

  1. May 2019
    Series B$60M3 new2 returning

    Reported by FinSMEs

  2. Nov 2018
    Series A$100M6 new

    Reported by FinSMEs

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Series A2018Series B2019Advantech CapitalPAGHudson Bay Capital Management LPLOrbiMedC VenturesHeritage Provider NetworkChinaVentureJanchor PartnersChina Venture(CVC)

Everyone who backed them

Advantech CapitalPrivate equity2rounds
PAGAngel2rounds
Hudson Bay Capital Management LPno record of our own yet1round, led 1
OrbiMedPrivate equity1round
C VenturesVC firm1round
Heritage Provider NetworkCorporate VC1round
ChinaVenturePrivate equity1round
Janchor PartnersPrivate equity1round
China Venture(CVC)no record of our own yet1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Alphamab Oncology

Who invested in Alphamab Oncology?

Alphamab Oncology's investors include Advantech Capital, PAG, Hudson Bay Capital Management LP, OrbiMed and C Ventures, and 4 more on record. Hudson Bay Capital Management LP led its latest round.

How much has Alphamab Oncology raised?

Alphamab Oncology has raised $160M across 2 rounds since 2018.

When did Alphamab Oncology last raise?

Alphamab Oncology's most recent round was a Series B of $60M in May 2019, led by Hudson Bay Capital Management LP.

What was Alphamab Oncology's biggest round?

Alphamab Oncology's largest round on record is $100M (Series A), in Nov 2018.

Who backed Alphamab Oncology first?

Alphamab Oncology's first round on record, in Nov 2018, was backed by OrbiMed, Advantech Capital and PAG and 3 others.

What stage is Alphamab Oncology at?

Alphamab Oncology's latest named round is a Series B, in May 2019.

Where is Alphamab Oncology based?

Alphamab Oncology is based in China.

Who led Alphamab Oncology's rounds?

Hudson Bay Capital Management LP led the Series B in 2019.

Companies like Alphamab Oncology

In the same sector, and raised in the last eighteen months.

Nutshell Therapeutics$40M · Sept 2026RNAimmune$4.5M · Aug 2026Gestala$22M · Mar 2026Adlai Nortye$190M · Feb 2026HitGen$39M · Nov 2025Adagene$83M · Jul 2025

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.

Open the investor searchOr these rounds in the app